2660227
SCDGP · Clinical drug group packinfluenza A virus (H3N2) antigen / influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Product
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus (H3N2) antigen / influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Product?
influenza A virus (H3N2) antigen / influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Product is coded as 2660227 in RxNorm.
What is RxNorm code 2660227?
2660227 is the RxNorm identifier for influenza A virus (H3N2) antigen / influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Product. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2660227?
2660227 is a SCDGP (Clinical drug group pack) in RxNorm.
What is the UMLS mapping for 2660227?
2660227 maps to UMLS C5844035.